Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert G Maki

Showing results (1-10 of 252) with videos related to

Pageof 26
Sort By:
Current Opinion in Oncology|May 25, 2006
Future directions for immunotherapeutic intervention against sarcomasRobert G Maki
The Oncologist|September 4, 2007
Gemcitabine and docetaxel in metastatic sarcoma: past, present, and futureRobert G Maki
Current Oncology Reports|April 14, 2007
Recent advances in therapy for gastrointestinal stromal tumorsRobert G Maki
Clinical Sarcoma Research|October 9, 2012
The rule of fives, a simple way to stratify risk for primary gastrointestinal stromal tumors (GIST)Robert G Maki
Oncology (Williston Park, N.Y.)|January 11, 2012
Comments regarding lung metastasis surgery for sarcomaRobert G Maki
The Lancet. Oncology|September 23, 2011
Eribulin in soft-tissue sarcomasRobert G Maki
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2010
Small is beautiful: insulin-like growth factors and their role in growth, development, and cancerRobert G Maki
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Ifosfamide in the neoadjuvant treatment of osteogenic sarcomaRobert G Maki
Cancer Investigation|August 29, 2002
Multidisciplinary management of soft-tissue sarcomasRobert G Maki
Journal of Surgical Oncology|February 21, 2008
Pediatric sarcomas occurring in adultsRobert G Maki
Pageof 26

Showing results (1-10 of 252) with videos related to

Sort By:
Pageof 26
Current Opinion in Oncology|May 25, 2006
Future directions for immunotherapeutic intervention against sarcomasRobert G Maki
The Oncologist|September 4, 2007
Gemcitabine and docetaxel in metastatic sarcoma: past, present, and futureRobert G Maki
Current Oncology Reports|April 14, 2007
Recent advances in therapy for gastrointestinal stromal tumorsRobert G Maki
Clinical Sarcoma Research|October 9, 2012
The rule of fives, a simple way to stratify risk for primary gastrointestinal stromal tumors (GIST)Robert G Maki
Oncology (Williston Park, N.Y.)|January 11, 2012
Comments regarding lung metastasis surgery for sarcomaRobert G Maki
The Lancet. Oncology|September 23, 2011
Eribulin in soft-tissue sarcomasRobert G Maki
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2010
Small is beautiful: insulin-like growth factors and their role in growth, development, and cancerRobert G Maki
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Ifosfamide in the neoadjuvant treatment of osteogenic sarcomaRobert G Maki
Cancer Investigation|August 29, 2002
Multidisciplinary management of soft-tissue sarcomasRobert G Maki
Journal of Surgical Oncology|February 21, 2008
Pediatric sarcomas occurring in adultsRobert G Maki
Pageof 26